CNBC’s Jim Cramer warned on Friday that volatility on Wall Street may not be over.Stocks endured a turbulent week as renewed concerns about the artificial intelligence…
The sinking AI trade and hotter-than-expected inflation data rattled last week’s stock market. But solid bank earnings and a rotation beyond tech gave us reasons for…
Kimberly-Clark shareholders were in need of some good news. We’ve been gifted plenty of it this week. On Thursday alone, the maker of Kleenex and Huggies…
Jim’s current faves include three tech names and a bank stock. Read More: Here’s a rapid-fire update on our 33-stock portfolio, including Cramer’s 6
Stocks kicked off September on shaky footing as higher oil prices and Treasury yields tested investors’ appetite for some of the market’s biggest artificial intelligence winners.…
CNBC’s Jim Cramer said Monday that investors shouldn’t fear the latest market rotation. Instead, he thinks it’s creating buying opportunities in several high-quality stocks that have…
Food and Drug Administration Commissioner Marty Makary told CNBC that he believes “everything should be over the counter” unless a drug is unsafe, addictive or requires…
Stocks bounced back Friday, but not enough to recover the week’s earlier losses. All three major averages posted gains — with the Dow Jones Industrial Average…
Kenvue Inc. Tylenol brand pain reliever for sale at a pharmacy in New York, US, on Wednesday, March 27, 2024. Bloomberg | Bloomberg | Getty ImagesShares…
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Wednesday’s key moments. 1.…